相关实验视频

Updated: Jun 29, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

血小板因子4和患有基本血小板细胞血症的患者的寿命:对抗性致病性类型的一个例子

William Bains¹

¹Five Alarm Bio Ltd., Hauxton, United Kingdom.

Rejuvenation research

|April 6, 2024

概括

敌对的致病性类型解释了疾病如何出乎意料地减少其他健康问题. 基本血小板血 (ET) 可能提供保护,防止因血小板血因子4 (PF4) 的升高而导致的衰老.

科学领域:

病理学病理学病理学
遗传学是一个遗传学.
免疫学免疫学免疫学

背景情况:

敌对性致病性质变异 (APP) 描述了疾病通过减少其他疾病而带来意想不到的好处的情况.
基本血小板血 (ET),以血小板升高为特征,呈现出血小板血风险增加的悖论,而没有减少预期寿命.
血小板因子4 (PF4) 在临床前模型中与缓解与年龄相关的免疫和认知功能下降有关.

研究的目的:

介绍和定义对抗性致病性类型 (APP) 的概念.
探索APP在解释实质性血栓瘤 (ET) 中观察到的预期寿命方面的潜在作用.
通过APP.的研究来确定对慢性疾病的潜在保护机制.

主要方法:

致病性类型的概念分析.
对关键血栓细胞血症 (ET) 临床数据的综述,关于发病率和死亡率.
审查关于血小板因子4 (PF4) 的现有研究及其对与衰老相关功能的影响.

主要成果:

ET患者的预期寿命没有出现预期的减少,尽管血栓形成风险较高.
在ET中血小板数升高导致PF4的产生增加.
在老鼠中,PF4已显示出降低与年龄相关的免疫和认知衰退的潜力.

结论:

在ET中增加的PF4的保护作用可能会抵消其血栓形成风险,说明APP.
APP为了解疾病表型和潜在的治疗点提供了一个新的框架.
调查缺乏预期死亡率降低的病理状况,可以揭示保护慢性疾病的因素.

关键词:

在PF4中,我们可以使用PF4.所有原因的死亡率.医疗健康的跨越范围长寿长寿是一个问题.血小板血小板是类型的类型.血小板细胞血症的发生.

更多相关视频

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Intracellular Signaling Affects Focal Adhesions

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...

Pleiotropy

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...

Structure and Function of Platelets

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...